Fig. 2
From: Radiological evaluation of malignant pleural mesothelioma - defining distant metastatic disease
Median overall survival (months) of entire MPM population referred for consideration of early phase clinical trials (a). Median overall survival (months) according to histopathological subtype (b). Median overall survival (months) according to presence of metastatic disease (c) or presence of locally invasive disease (d). In those with metastatic disease median overall survival (months) according to presence or absence of peritoneal only metastasis (e), bone only metastasis, (f) visceral only metastasis (f), and brain only metastasis (g). OS: overall survival